The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References

Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below. 

57 – Ying Bao et al., The New England Journal of Medicine 2013, 2001–11, 369, November 2013

Association of Nut Consumption with Total and Cause-Specific Mortality

58 – Edward Bitok and Joan Sabaté, Progress in Cardiovascular Diseases 61, no. 1, 33–37, May 2018

Nuts and Cardiovascular Disease

58 – Narjes Gorji, Reihaneh Moeni, and Zahra Memariani, Pharmacological Research 129, 115–27, March 2018

Almond, Hazelnut and Walnut, Three Nuts for Neuroprotection in Alzheimer’s Disease: A Neuropharmacological Review of Their Bioactive Constituents

58 – Marshall Miller et al., Experimental Gerontology 94, 24–28, August 2017

Role of Fruits, Nuts, and Vegetables in Maintaining Cognitive Health

59 – Raj Kishor Gupta, Shivraj Singh Gangoliya, and Nand Kumar Singh, Journal of Food Science and Technology 52, no. 2, 676–84, February 2015

Reduction of Phytic Acid and Enhancement of Bioavailable Micronutrients in Food Grains

60 – Wiebke Schlörmann et al., Food Chemistry 180, 77–85, August 2015

Influence of Roasting Conditions on Health-Related Compounds in Different Nuts

61 – National Institutes of Health, Office of Dietary Supplements, last updated July 11, 2019

Selenium

62 – Lenore Arab and Alfonso Ang, The Journal of Nutrition Health and Aging 19, no. 3, 284–90, March 2015

A Cross Sectional Study of the Association between Walnut Consumption and Cognitive Function among Adult US Populations Represented in NHANES

63 – Gorji, Moeni, and Memariani,

Almond, Hazelnut and Walnut

64 – Simone Perna et al., Nutrients 8, no. 12, 747, December 2016

Effects of Hazelnut Consumption on Blood Lipids and Body Weight: A Systematic Review and Bayesian Meta-Analysis